Kayla Eeg, PA
Physician Assistant · Akron
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
- Since medical school
- 6 years
- Graduated 2020
Offices
6 locations · Cleveland Clinic · 6,954 clinicians in this group
Hospitals listed: Cleveland Clinic · Fairview Hospital · Hillcrest Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kayla Eeg’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Cleveland ClinicCleveland, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Cleveland Clinic, which runs 21 hospitals in 2 statesHome of Case Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.51 (1.39 to 1.62), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.7 (2.44 to 2.96) · 20,161 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.6 (11.3 to 14.1) · 2,120 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 6.46 (4.79 to 8.13) · 7,167 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 3.77 (2.46 to 5.08) · 7,190 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.299, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.649, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.477, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 4.1 (3.4 to 5) · 2,120 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 0.9) · 4,396 cases, Jan 2024 – Dec 2024
- Fairview HospitalCleveland, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Cleveland Clinic, which runs 21 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.73 (0.49 to 0.97), Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.41 (0 to 5.1) · 845 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.09 (0 to 0.59) · 7,214 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.358, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.396, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.471, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 832 cases, Jan 2024 – Dec 2024
- Hillcrest HospitalMayfield Heights, OHAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPart of Cleveland Clinic, which runs 21 hospitals in 2 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.59 (0.35 to 0.84), Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 3.79 (0 to 8.86) · 958 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.18, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.4, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.4 (2.3 to 4.9) · 377 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Cleveland Clinic
Behind the star rating — Deaths: 6 better, 2 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 4 better, 4 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.51 (1.39 to 1.62) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.7 (2.44 to 2.96) · 20,161 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (11.3 to 14.1) · 2,120 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.46 (4.79 to 8.13) · 7,167 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.77 (2.46 to 5.08) · 7,190 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.299 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.649 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.477 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.1 (3.4 to 5) · 2,120 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 0.9) · 4,396 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0.29 to 1.3) · 6,469 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.75 (143.33 to 200.18) · 527 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 389 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.3 · 283 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7 · 981 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.6 · 312 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.9 · 438 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2 · 9,668 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0.01 to 0.29) · 19,048 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.13 to 0.42) · 23,325 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.41 (3.44 to 5.38) · 10,735 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.79 (1.2 to 2.38) · 7,312 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (2.23 to 3.76) · 8,769 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.12 (1.11 to 3.13) · 2,849 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 328 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.75 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.966 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 811 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 1,840 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 25.3 · 442 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12 · 1,224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44 · 375 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 618 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 343 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.6 · 447 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 392 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (11 to 14.4) · 14,847 cases | No different | Jan 2022 – Dec 2024 |
What patients said (7,072 patients answered, 25% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Fairview Hospital
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.73 (0.49 to 0.97) | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.41 (0 to 5.1) · 845 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.09 (0 to 0.59) · 7,214 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.358 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.471 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 832 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.86 (0.07 to 1.65) · 1,824 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 172.39 (124.06 to 220.71) · 97 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.5 · 215 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.5 · 265 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.6 · 621 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 529 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 368 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.2 · 4,756 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.02 to 0.38) · 8,073 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.11 to 0.48) · 8,437 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.2 (2.41 to 5.98) · 2,050 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.27 to 3.02) · 902 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.79 to 3.42) · 1,921 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.31 (3.43 to 13.2) · 858 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 619 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 1.028 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.529 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 482 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 1,250 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 4.7 · 317 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.9 · 725 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 8.1 · 556 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 1,068 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (3 to 6.1) · 301 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.5 (9 to 14.5) · 301 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 559 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.5) · 216 cases | No different | Jan 2022 – Dec 2024 |
What patients said (2,166 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Hillcrest Hospital
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 5 better, 2 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.59 (0.35 to 0.84) | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.79 (0 to 8.86) · 958 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.18 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.4 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.4 (2.3 to 4.9) · 377 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0.11 to 1.77) · 2,481 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.94 (109.05 to 208.84) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.5 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 204 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 325 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.1 · 917 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.1 · 860 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 421 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 6,421 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 11,381 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,562 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.86 (1.12 to 4.6) · 2,493 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1 (0 to 2.34) · 939 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.54 (0.22 to 2.86) · 2,293 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.22 (1.28 to 7.16) · 930 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.41 (0.04 to 2.78) · 659 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.67) · 10,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 137 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.655 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.625 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.091 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 587 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 1,482 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.3 · 361 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 16.4 · 1,042 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.7 · 909 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.4 · 1,400 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.4 (9.8 to 15.3) · 377 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 146 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 156 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 450 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.5 to 17.4) · 839 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,407 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,161 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$2,524
Medicare paid this office $2,524 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of impacted ear wax | 13 | $444 | $32 |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Removal of impacted ear wax | – | – | 14 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 73 · Women 52% · Health risk score 1.48. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 56%.
The office billed $47,222, Medicare allowed $3,144 and paid $2,524; for 39 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 25 | 39 | 73 | 1.48 | $47,222 | $2,524 |
| 2023 | 13 | 19 | 77 | 2.68 | $15,630 | $1,670 |
| 2022 | 29 | 34 | 76 | 1.45 | $9,316 | $1,788 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 1 service
| Return visit (30+ min) | 22 | $1,554 | $71 |
Drugs they prescribed that Part D paid
$3,783
Pharmacies billed $3,783 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 8% of their Part D prescriptions (15 of 184) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
180 generic and fewer than 11 brand-name prescriptions · $3,783 in drug cost · 40 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 21 | $278 | $13 |
| Pentoxifylline | 11 | $243 | $22 |
| Fluticasone Propionate | 18 | $114 | $6 |
| Pantoprazole | 12 | $13 | $1 |
Year by year
| 2024 | 184 | 72 | 8% (15) | None | $3,783 |
| 2023 | 474 | 147 | 3% (16) | 20% | $58,783 |
| 2022 | 628 | 122 | 0% (0) | 15% | $62,741 |
| 2021 | 169 | 60 | 0% (0) | 27% | $33,779 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Eliquis | 33 | $22,426 | $680 |
| Entresto | 19 | $12,352 | $650 |
| Brilinta | 24 | $11,148 | $465 |
| Ipratropium | 11 | $647 | $59 |
| Ranolazine Er | 12 | $644 | $54 |
| Clopidogrel | 51 | $484 | $9 |
| Atorvastatin | 13 | $417 | $32 |
| Metoprolol | 26 | $370 | $14 |
| Digoxin | 11 | $320 | $29 |
| Fluticasone Propionate | 17 | $264 | $16 |
| Pantoprazole | 21 | $130 | $6 |
| Metoprolol | 12 | $82 | $7 |
| Furosemide | 12 | $54 | $4 |
2022: 16 drugs
| Eliquis | 24 | $21,395 | $891 |
| Brilinta | 28 | $16,250 | $580 |
| Entresto | 11 | $7,142 | $649 |
| Ranolazine Er | 15 | $956 | $64 |
| Clopidogrel | 109 | $901 | $8 |
| Bumetanide | 12 | $736 | $61 |
| Isosorbide Mononitrate Er | 64 | $730 | $11 |
| Metoprolol | 51 | $645 | $13 |
| Pantoprazole | 70 | $559 | $8 |
| Atorvastatin | 26 | $405 | $16 |
| Furosemide | 41 | $202 | $5 |
| Metoprolol | 25 | $157 | $6 |
| Hydralazine | 12 | $147 | $12 |
| Amiodarone | 11 | $81 | $7 |
| Carvedilol | 11 | $64 | $6 |
| Lisinopril | 16 | $61 | $4 |
2021: 6 drugs
| Brilinta | 12 | $8,659 | $722 |
| Bumetanide | 15 | $904 | $60 |
| Metoprolol | 13 | $229 | $18 |
| Clopidogrel | 14 | $189 | $13 |
| Atorvastatin | 17 | $170 | $10 |
| Metoprolol | 14 | $102 | $7 |
Money from drug and device companies
$362 in 2023
| 2023 | 8 | 16 | None | $362 |
| 2022 | 12 | 49 | None | $2,042 |
| 2021 | 11 | 32 | None | $1,095 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $146 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $64 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $39 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $36 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $29 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $18 | 1 payment
|
See all 16 published payments
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2023-04-04 | Lifevest | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2023-03-22 | Farxiga | $15 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2023-03-22 | Lifevest | $17 |
| Novartis Pharmaceuticals | Meals · 2023-03-21 | Entresto | $20 |
| Merck Sharp & Dohme | Meals · 2023-03-17 | Verquvo | $15 |
| Janssen Pharmaceuticals | Meals · 2023-03-15 | Xarelto | $125 |
| Merck Sharp & Dohme | Meals · 2023-03-14 | Verquvo | $14 |
| Janssen Pharmaceuticals | Meals · 2023-02-28 | Xarelto | $17 |
| Sanofi-Aventis U.S. | Meals · 2023-02-27 | Multaq | $15 |
| Janssen Pharmaceuticals | Meals · 2023-02-27 | Xarelto | $4 |
| AstraZeneca Pharmaceuticals LP | Meals · 2023-02-22 | Farxiga | $15 |
| Merck Sharp & Dohme | Meals · 2023-02-14 | Verquvo | $18 |
| Novartis Pharmaceuticals | Meals · 2023-02-08 | Entresto | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2023-01-31 | Camzyos | $18 |
| Merck Sharp & Dohme | Meals · 2023-01-19 | Verquvo | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2023-01-05 | Jardiance | $14 |
See earlier years (2022, 2021)
2022: $2,042
| Inari Medical | Flowtriever Catheter, S | $1,151 | 8 payments
|
| Janssen Pharmaceuticals | Xarelto | $238 | 9 payments
|
| Novartis Pharmaceuticals | Entresto | $163 | 9 payments
|
| Esperion Therapeutics | Nexlizet | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $92 | 6 payments
|
| Merck Sharp & Dohme | Verquvo | $73 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $61 | 4 payments
|
| Amgen | Repatha | $44 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $35 | 2 payments
|
| Abbott Laboratories | Amplatzer | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
| Novo Nordisk | Ozempic | $13 | 1 payment
|
2021: $1,095
| Abbott Laboratories | Amplatzer Occluders | $237 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $208 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $168 | 4 payments
|
| Amgen | Repatha | $154 | 3 payments
|
| Esperion Therapeutics | Nexlizet | $138 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $84 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $29 | 2 payments
|
| Boston Scientific | Watchman | $24 | 1 payment
|
| Novo Nordisk | Ozempic | $19 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 93.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689270225
- Licence
- PA MA061967
- Group
- Cleveland Clinic
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- PA 103913499
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 490 E North Ave Ste 515, Pittsburgh, PA, 15212
- NPI first listed
- 2020-12-09
- NPI last updated
- 2023-03-22
- NPI record certified
- 2023-03-22
This is when the NPI record was last certified, not a medical board exam.